The experimental study of the biological activity and anti-tumor effects of CD3AK cells in human umbilical cord blood

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 26, Issue 1, 2005, Pages

  Wei, Xucang ^a   Xing, Peini ^a   Zhao, Wenli ^a   Zhai, Xinhui ^a   Li, Meisheng ^a   Guo, Liang ^b  

^a SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^b XI AN CENTRAL HOSPITAL   (China)

Author keywords

Anti tumor; Biological activity; CD3AK; CD3McAb; Cord blood; rhIL 2

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD3 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MONOCLONAL ANTIBODY CD3; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; CANCER IMMUNOTHERAPY; CD3 ANTIGEN ACTIVATING KILLING CELL; CELL COUNT; CELL CULTURE; CELL KILLING; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; MONONUCLEAR CELL; PHENOTYPE; STAINING; SUPERNATANT; TAPAN BLUE STAINING; TARGET CELL; TUMOR CELL; UMBILICAL CORD BLOOD;

EID: 14844333068     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. 3 McAb [J]. Cancer Immunol Immunother, 1996, 42(6): 369-375.
2. 3-activated killer cells and interleukin-2 [J]. J Clin Oncol, 1993, 11(4): 652-660.
3. 3 antibody-induced activated killer cells: cytokines as the additional signals for activation of killer cells in effector phase to mediate slow lysis [J]. Cell Immunol, 1991, 135(2): 273-284.